Jul 21, 2018

Online portal of thousands of clinical trials could aid disease research

Posted by in categories: biotech/medical, health, policy

Vivli, which spun out of a policy think tank at Harvard University–affiliated Brigham and Women’s Hospital in Boston, is part of a push to encourage drug developers to share trial data—even negative results, findings that show a treatment has no benefit. Companies seeking U.S. regulatory approval for a drug, as well as investigators funded by the National Institutes of Health, must post limited, summary results on But many researchers and policy analysts believe sharing detailed raw data on individual patients, stripped of identifying information, would be valuable. Researchers could confirm that a drug works, look for side effects, or explore new questions.

Vivli aims to ease sharing of anonymized clinical studies.

Read more

Comments are closed.